World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, Ninomiya Y, Yamamoto M, Kazuno A, Nabeshima K, Nishi T, Mori M. Immunotherapy for esophageal cancer: Where are we now and where can we go. World J Gastroenterol 2024; 30(19): 2496-2501 [PMID: 38817664 DOI: 10.3748/wjg.v30.i19.2496]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i19/2496.htm

(111) (111) (0) (0) (0) (9) (1) (6240) (40)

Number	Citing Articles
1	Zhaoyang Yan, Tongxin Xu, Juntao Lu, Xiaoxu Li, Xinhao Wang, Zhaokun Hu, Wei Guo. Prognostic significance of perineural invasion in esophageal squamous cell carcinoma: A large-scale propensity score matching analysis with long-term follow-up outcomes. European Journal of Surgical Oncology 2026; 52(6) doi: 10.1016/j.ejso.2026.111811
2	Song Zhang, Chang Su, Zhi-Bo Shen, Jia Huo, Jun-Ping Yang. Outcomes and Safety of PD-1 Blockades Plus Anlotinib Regimen in Previously-Treated Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective, Exploratory Study. Drug Design, Development and Therapy 2026; doi: 10.2147/DDDT.S587621
3	Xuan Zheng, Yishuang Cui, Xuemin Yao, Yanan Wu, Yanlei Ge, Ye Jin, Junqing Gan, Weinan Yao, Yanna Bi, Guogui Sun, Mohammad H. Ghazimoradi. Integrative bioinformatics and experiments identify RIBC2 as a key regulator in the esophageal cancer. PLOS One 2026; 21(2) doi: 10.1371/journal.pone.0340850
4	Hong-Jie Yang, Wei-Feng Zhao, Min Hu, Ya-Xuan Niu. Expression of stem cell marker musashi-1 and its relationship with survival prognosis in patients with resectable esophageal squamous cell carcinoma. World Journal of Stem Cells 2025; 17(8): 107013 doi: 10.4252/wjsc.v17.i8.107013 Abstract(226) \| Core Tip(241) \| Full Article(HTML)(443) \| Full Article (PDF)-618K(85) \| Full Article with Cover (PDF)-884K(74) \| Full Article (XML)-107K(47) \| Audio-94K(11) \| Peer-Review Report-289K(60) \| Answering Reviewers-89K(48) \| Times Cited (0) \| Total Visits (996) \| Open
5	Qian Wang, Bo Bian, Lifang Zhang, Peipei Duan, Hua Bian, Guangji Zhang, Kai Li. Fraxinellone Inhibited Immune Evasion and Cell Growth by Inactivating HIF‐1α/STAT3/PD‐L1 Signaling in Esophageal Squamous Cell Carcinoma. Journal of Biochemical and Molecular Toxicology 2026; 40(2) doi: 10.1002/jbt.70732
6	Xiaodan Liu, Shengju Ren, Xinyang Li, Xiang Cheng, Yujing Fang, Shuo Zhang, Yidi Zhao, Wang Ma, Tengfei Zhang. Prognostic Value of Inflammatory and Nutritional Markers in Advanced Esophageal Squamous Cell Carcinoma Treated with Immunotherapy: A Retrospective Cohort Study. Journal of Inflammation Research 2025; doi: 10.2147/JIR.S547500
7	‏Amany I. Almars, Sameerah Shaheen, Nahlah M. Ghouth, Iman S. Abumansour, Asim Abdulaziz Khogeer, Fayez Alsulaimani, Ahmed M. Basri, Nasser A. Elhawary, Tabinda Hasan, Hailah M. Almohaimeed. Harnessing biomarkers to guide immunotherapy in esophageal cancer: toward precision oncology. Clinical and Translational Oncology 2025; 28(3) doi: 10.1007/s12094-025-04051-4
8	Sung Eun Kim, Kyoungwon Jung, Moo In Park. Immunotherapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma. Journal of Digestive Cancer Research 2024; 12(2) doi: 10.52927/jdcr.2024.12.2.72
9	Xiao-Lan Guo, Qiang Ma, Xiao-Wu Zhong, Man Luo, Mao-Ju Tang, Xiao Liu, Zi-Chun Yuan, Lei Xu, Qing-Rong Li, Qin Wang. BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation. World Journal of Gastrointestinal Oncology 2025; 17(1): 99376 doi: 10.4251/wjgo.v17.i1.99376 Abstract(475) \| Core Tip(439) \| Full Article(HTML)(1930) \| Full Article (PDF)-47572K(216) \| Full Article with Cover (PDF)-47861K(152) \| Full Article (XML)-94K(120) \| Audio-361K(24) \| Peer-Review Report-174K(106) \| Answering Reviewers-87K(101) \| Times Cited (5) \| Total Visits (2759) \| Open
10	Seungbyn Baek, Junha Cha, Min Hee Hong, Gamin Kim, Yoon Woo Koh, Dahee Kim, Wonrak Son, Chan‐Young Ock, Seungeun Lee, Martin Hemberg, Seong Yong Park, Hye Ryun Kim, Insuk Lee. Comparative single‐cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses. Cancer Communications 2025; 45(9) doi: 10.1002/cac2.70046
11	Dimitris Zacharoulis, Marina Nektaria Kouliou, Konstantinos Eleftherios Koumarelas, Sara Eirini Agko, Grigorios Christodoulidis. Advancements and challenges in the treatment of esophageal cancer: A comprehensive review. World Journal of Clinical Oncology 2024; 15(12): 1463-1467 doi: 10.5306/wjco.v15.i12.1463 Abstract(654) \| Core Tip(760) \| Full Article(HTML)(2789) \| Full Article (PDF)-372K(196) \| Full Article with Cover (PDF)-611K(146) \| Full Article (XML)-52K(119) \| Audio-411K(19) \| Peer-Review Report-215K(108) \| Answering Reviewers-63K(106) \| Times Cited (8) \| Total Visits (3250) \| Open
12	Huilai Lv, Bisong Chen, Chunyue Gai, Yu Liu, Weilu Ding, Mingbo Wang, Kangbo Sun, Fan Zhang, Yonggang Zhu, Zhenhua Li, Ziqiang Tian. Strategies of neoadjuvant therapy in esophageal cancer: a study on the effects of treatment frequency and surgery interval. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1642765
13	Zijian Qiu, Mixue Sun, Chunyan Dai, Xiaoping Zhu. Immunotherapy-associated autoimmune hemolytic anemia induced by anti-PD-1 therapy in esophageal cancer: A case report and literature review. Medicine 2025; 104(15) doi: 10.1097/MD.0000000000042174
14	Qiang Zhao, Liang Wang, Xun Yang, Jifeng Feng, Qixun Chen. Pretreatment immune-inflammatory prognostic score in predicting clinical outcomes in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1617681
15	Wei Chen, Boyan Chen, Chunbin Hu, Qiance Wei, Jiayi Chen, Wenxin Xue, Shui Liu, Lichaoyue Sun, Lili Zhang, Shuo Fan. Comparative safety profiles of first-line immunotherapy regimens in advanced esophageal squamous cell carcinoma: a network meta-analysis focusing on toxicity stratification. Frontiers in Oncology 2026; 15 doi: 10.3389/fonc.2025.1700236
16	Xihao Xie, Hai Zhang, Haiquan He, Bomeng Wu, Ying Chen, Wanli Lin, Qingyi Feng, Qunqing Chen. Postoperative adjuvant immunotherapy for pathological stage II–IVa esophageal squamous cell carcinoma after radical surgery does not improve disease-free recurrence rates. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1517001
17	Jian Gao, Qiming Wang, Fangqiu Fu, Yue Zhao, Teng Yang, Xiangze Li, Yihua Sun, Hong Hu, Longfei Ma, Longsheng Miao, Xiaoyang Luo, Ting Ye, Yiliang Zhang, Yang Zhang, Ziling Huang, Hang Li, Longlong Shao, Midie Xu, Kuaile Zhao, Shiyue Zhang, Mou Zhang, Jun Wang, Chong Dai, Xiaoxiao Shang, Tingyi An, Yawei Zhang, Jiaqing Xiang, Zhiwei Cao, Bin Li, Haiquan Chen. Comprehensive genomic and transcriptomic analyses reveal prognostic stratification for esophageal squamous cell carcinoma. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02306-8
18	Weijia Jiang, Wanren Peng, Dong Qian, Genhe Wang, Hong Qian, Wenxia Deng, Zishu Wang, Zhiyong Wei, Tai Ma, Dong Zhao, Yifu He, Chenghui Li, Gang Wang, Zhongxian Zheng, Xinglai Guo, Shaojin Zhu, Liming Xia, Xiangde Jiang, Jie Wei, Xinzhong Li, Guoping Sun. Efficacy and safety of camrelizumab-based regimens in advanced squamous cell carcinoma patients: a prospective multicenter study. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1767096
19	Guo Lin, Fan Ge, Yunsong Liu, Yu Men, Zhouguang Hui. Optimal Neoadjuvant Approach for Resectable Esophageal Cancer in the Era of Immunotherapy. International Journal of Cancer 2026; doi: 10.1002/ijc.70521
20	Hossein Taghizadeh, Harun Fajkovic. Immunotherapy in the Management of Penile Cancer—A Systematic Review. Cancers 2025; 17(5) doi: 10.3390/cancers17050883
21	Yanxia Hu, Yuqin Cao, Xiaolong Wang, Shiyu Zhang, Weiqing Zhang, Hecheng Li. Neoadjuvant Radio-Chemo-Immunotherapy Impact on Postoperative Patient-Reported Outcomes in Oesophageal Cancer. European Journal of Cardio-Thoracic Surgery 2025; 67(12) doi: 10.1093/ejcts/ezaf414
22	Zihan Zhao, Dexia Chen, Xiaolong Wei, Shuman Li, Xinke Zhang, Weihao Lin, Xueyi Zheng, Ke Zheng, Shuyang Wu, Xiaobo Wen, Baishen Zhang, Yan Zheng, Shaobin Chen, Chuanmiao Xie, Shuangjiang Li, Dan Xie, Ruixuan Wang, Wenqun Xing, Jian Zhou, Muyan Cai. A multimodal synergistic model for personalized neoadjuvant immunochemotherapy in esophageal cancer. Cell Reports Medicine 2025; 6(12) doi: 10.1016/j.xcrm.2025.102479
23	Xiaodi Yin, Huihong Cai, Aohua Zhang, Weihan Zheng, Jiahui Zhao, Jun Ma. NK cell function down regulated by HMGB2 through ANGPT1/PI3K/AKT pathway and its effect on esophageal squamous carcinoma cells. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1666199
24	Yawei Wang, Ye Hu, Yi Qin, Xiangfeng Jin, Yandong Zhao. Low Serum Interleukin-6 Levels Enhance the Efficacy of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma. Cancer Biotherapy and Radiopharmaceuticals 2025; 40(10) doi: 10.1177/10849785251360550
25	Hong-Wei Gao, Kai-Fu Chang, Xiao-Fan Huang, Peng-Yun Hung, Ming-Chang Hsieh, Nu-Man Tsai. Juniperus indica Bertol Extract Combined with 5-Fluorouracil Synergistically Suppresses the Growth of Esophageal Squamous Cell Carcinoma Cells. Natural Product Communications 2025; 20(2) doi: 10.1177/1934578X251324602
26	Vivek Uttam, Manjit Kaur Rana, Gautam Sethi, Aklank Jain. Long non-coding RNAs as regulators of immune signaling pathways in esophageal cancer. Biochemical Pharmacology 2026; 250 doi: 10.1016/j.bcp.2026.117987
27	Xin Chen. Ultrasound targeted microbubble delivery of JMJD2A siRNA induces ferroptosis remodels the tumor immune microenvironment and inhibits esophageal squamous cell carcinoma progression. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-04583-3
28	Huijun Jia, Yifan Gong, Chengguang Zhao, Hongyu Wei, Qiwei Zang. Mapping research trends in esophageal cancer immunotherapy: A decade of thematic evolution and emerging priorities. Human Vaccines & Immunotherapeutics 2026; 22(1) doi: 10.1080/21645515.2026.2635243
29	Chunxiao Gao, Ting Zhang, Guangyuan Li, Weishan Zhang, Honglin Chen, Diefei Li, Jixuan Xu, Mengxue Li, Ruihong Wang, Yamin Xing, Jian Zhan, Zhentai Ren, Xia Xue, Wulong Liang, Xiangdong Sun, Xiaojuan Zhang, Xinfeng Liang, Hongqiao Zhan, Zisen Zhang, Xiufeng Chu. Overcoming chemoresistance in esophageal cancer with synergistic strategies. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1784325
30	Atsuto Katano. Palliative external beam radiotherapy for dysphagia management in advanced esophageal cancer: a narrative perspective. Oncologie 2025; 27(3) doi: 10.1515/oncologie-2025-0087
31	Siyuan Luan, Jing Chen, Yuhao Peng, Jiaqiao Liang, Jun Sun, Xin Xiao, Shangwei Sun, Yushang Yang, Xiaoxi Zeng, Jin Zhou, Zhong Wu, Yong Yuan. Global burden of esophageal cancer attributable to tobacco, alcohol, and diet from 1990 to 2021, with projections to 2040. Chinese Medical Journal 2025; doi: 10.1097/CM9.0000000000003884
32	Chunyan Yan, Zhengxiong Li, Jiayan Li, Ruiqin Huang, Shuqing Li, Ruigang Diao. Cost-effectiveness of sugemalimab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced oesophageal squamous cell carcinoma in China. BMJ Open 2026; 16(2) doi: 10.1136/bmjopen-2024-098021
33	Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875 Abstract(816) \| Core Tip(834) \| Full Article(HTML)(1760) \| Full Article (PDF)-410K(153) \| Full Article with Cover (PDF)-639K(208) \| Full Article (XML)-117K(128) \| Audio-785K(15) \| Peer-Review Report-230K(122) \| Answering Reviewers-209K(128) \| Times Cited (0) \| Total Visits (2249) \| Open
34	Yoshiaki Shoji, Kohei Kanamori, Kazuo Koyanagi, Tetsuya Otsuka, Rie Nakashima, Kohei Tajima, Mika Ogimi, Yamato Ninomiya, Miho Yamamoto, Akihito Kazuno, Takayuki Nishi, Masaki Mori. Conversion surgery for esophageal and esophagogastric junction cancer. International Journal of Clinical Oncology 2024; 29(12) doi: 10.1007/s10147-024-02639-4
35	Shilong Wu, Chenyang Xu, Huafeng Liu. Case report: Toxic epidermal necrolysis induced by tislelizumab in a patient with esophageal squamous cell carcinoma. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1522525
36	Yingjie Sun, Yuheng Tang, Qi Qi, Jianyu Pang, Yongzhi Chen, Hui Wang, Jiaxiang Liang, Wenru Tang. 101 Machine Learning Algorithms for Mining Esophageal Squamous Cell Carcinoma Neoantigen Prognostic Models in Single-Cell Data. International Journal of Molecular Sciences 2025; 26(7) doi: 10.3390/ijms26073373
37	Yaru Wang, Qibing Wu. Development and Validation of an Interpretable ML Model for Survival Prediction in Unresectable ESCC with Immunochemotherapy. Cancer Management and Research 2025; doi: 10.2147/CMAR.S532944
38	Jian-Zhou Tian, Li Zhang, Fu-Yong Lin, Ren-Jiao He, Wen-Rong Tian, Liu Yan, Guo-Xin Huang, Jin-Wei Ai, Bin Pei, De-Sheng Li. The efficacy and safety of PD-1 inhibitors combined with chemotherapy treatment for advanced esophageal cancer: a network meta-analysis. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1515263
39	Kunrong Yang, Zhenzhou Xiao, Ran Huo, Zhaolei Cui, Sha Huang, Jiaqing Yu, Junkai Wang, Xiaoqian Hong, Min Dong, Xiaopeng Lan, Kuancan Liu. Selection and validation of a cell-internalizing DNA aptamer targeting esophageal squamous cell carcinoma. European Journal of Pharmacology 2025; 1008 doi: 10.1016/j.ejphar.2025.178372
40	Tianhang Zhang, Xiao Chen, Jianhua Wu, Jiasong Li, Zhukun Qin, Ruijie Cao, Wei Guo, Zhanjun Guo, Haiyan Fan. Impact of immune-related adverse events on treatment outcomes in advanced esophageal squamous cell carcinoma treated with immune checkpoint inhibitors. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1741482
41	Wei Wei, Xiao-Lei Zhang, Hong-Zhen Wang, Lin-Lin Wang, Jing-Li Wen, Xin Han, Qian Liu. Application of deep learning models in the pathological classification and staging of esophageal cancer: A focus on Wave-Vision Transformer. World Journal of Gastroenterology 2025; 31(19): 104897 doi: 10.3748/wjg.v31.i19.104897 Abstract(386) \| Core Tip(359) \| Full Article(HTML)(1542) \| Full Article (PDF)-6735K(171) \| Full Article with Cover (PDF)-7051K(167) \| Full Article (XML)-165K(90) \| Audio-1470K(20) \| Peer-Review Report-270K(91) \| Answering Reviewers-154K(97) \| Supplementary Material-1014K(80) \| Times Cited (3) \| Total Visits (2558) \| Open